Dr. Yin Ye, CEO of BGI Group, recently visited the Kingdom of Saudi Arabia, where he held comprehensive talks with Saudi Arabian government officials and business partners and signed multi-disciplinary cooperation agreements with Saudi Arabian public and government units.

Dr. Yin attended the opening ceremony of Genalive Medical Laboratory, an independent joint venture clinical laboratory between BGI and a local partner. "Genalive represents a transformative advancement in the Saudi healthcare industry," he said. "By uniting the strengths of various parties, we can unlock the untapped potential of genomics and provide Saudi healthcare professionals with the tools they need to deliver personalized care for those in need."

Dr. Yin Ye (first from the left, first row) attended the opening ceremony of Genalive Medical Laboratory.

 Under the invitation of the event organizer, Dr. Yin spoke as a panel speaker at the 10th Arab-China Business Conference, a high-level event organized by the Ministry of Investment under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince, and Prime Minister of Saudi Arabia.

Dr. Yin introduced the achievements of BGI Group in the field of genomics and discussed the challenges and opportunities in biotechnology with other panellists. He also highlighted the importance of international collaboration and cross-border innovation in addressing common challenges in global health.

"We must keep cutting-edge technologies affordable, accessible, and equitable for all; this is very important," said Dr. Yin.

 Dr. Yin Ye spoke on the 'Healthcare and Biopharma' panel at the 10th Arab-China Business Conference (Source: the 10th Arab-China Business Conference).

 During the panel discussion, H.E. Hisham bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority (SFDA), praised BGI's contribution to the fight against COVID-19 in Saudi Arabia, citing it as an excellent example of healthcare cooperation between Saudi Arabia and China.

On the sidelines of the conference, with H.E. Khalid Al-Falih, Minister of Investment, H.E. Eng. Mansour Bin Hilal Al Mushaiti, Vice Minister of Environment, Water, and Agriculture, and Dr. Yin as witnesses, Mr. Ma Zhe, BGI Group's Western Asia Regional General Manager, signed a cooperation agreement with the Ministry of Environment, Water, and Agriculture (MEWA). The agreement focuses on biogenetic resources preservation, agriculture modernization, and environmental management, fully supporting Saudi Arabia's Green Initiative of Vision 2030.

Witnessed by H.E. Khalid Al-Falih, Minister of Investment (in the middle), H.E. Eng. Mansour Bin Hilal Al Mushaiti, Vice Minister of Environment, Water, and Agriculture (first from the right), and Dr. Yin Ye, Mr. Ma Zhe (first from the left) signed a cooperation agreement with the Ministry of Environment, Water, and Agriculture (MEWA).

Dr. Yin also signed a strategic framework cooperation agreement with King Faisal Specialist Hospital & Research Centre (KFSH&RC).

Dr. Yin Ye signed a strategic framework cooperation agreement with King Faisal Specialist Hospital & Research Centre (KSFH&RC).

 During his trip, Dr. Yin also met with senior leadership members from Saudi Basic Industries Corporation (SABIC), the National Unified Procurement Company (NUPCO), the National Center for Vegetation Cover Development and Combating Desertification (NCVC), the Ministry of Environment, Water and Agriculture (MEWA), King Saud University (KSU), and other senior executives and officials.

Dr. Yin Ye and the BGI delegation met with the executives of the National Unified Procurement Company (NUPCO).

Dr. Yin Ye visited the National Center for Vegetation Cover Development and Combating Desertification (NCVC).

 Dr. Yin Ye and his team met with officials from the Ministry of Environment, Water and Agriculture (MEWA).

 Dr Yin Ye and his team visited the King Saud University (KSU).

Through this visit, BGI Group endeavours to further strengthen partnerships, exchange knowledge, and explore innovative opportunities that will pave the way for transformative advancements in healthcare, life sciences, agriculture, and various other industries in Saudi Arabia. This is another testimony of BGI Group's commitment to international cooperation and benefiting the world with genomics technology.